Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-17 Purchase | 2022-06-22 4:47 pm | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 766,667 | $15 | $11,500,005 | 766,667 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-26 7:24 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:17 pm | N/A 2033-06-05 | Third Harmonic Bio Inc. | THRD | Gladstone Michael Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 5:04 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Gladstone Michael Director | 13,667 | $0 | 13,667 (Direct) | View |
| 2023-03-06 Disposition | 2023-03-08 5:04 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Gladstone Michael Director | 13,667 | $0 | 13,667 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-27 4:49 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Gladstone Michael Director | 13,667 | $0 | 13,667 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 8:27 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 28,700 | $0 | 28,700 (Direct) | View |
Ownership | 2021-05-26 9:03 pm | N/A 2031-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 0 | $0 | 63,000 (Direct) | View |